Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix H. LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00p -1.20% 82.50p 81.00p 84.00p 83.50p 82.50p 83.50p 27,795 08:19:09
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.2 1.7 2.4 34.0 70.49

Optibiotix H. Share Discussion Threads

Showing 50426 to 50445 of 50450 messages
Chat Pages: 2018  2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  Older
DateSubjectAuthorDiscuss
21/3/2019
10:19
Trouble is, what money?
rayrac
21/3/2019
10:09
We all know it here but alas a different AIM market than 10-15 years ago. Back then a stock like OPTI with it's mega impressive RNS flow would already be £2+ Now there is zero enterprise value applied and we are just put in a bucket of general blue sky stocks with the attitude of "Yeah Yeah another RNS .. Yawnnnn, show me the money"
onedayrodders
21/3/2019
10:07
Grow up sunshine.
scotty1
20/3/2019
22:33
Quite the reverse aspex. That’s why you have a 6% spread, not all are gullible out there!
rayrac
20/3/2019
18:05
That really is some list, Parob. Thanks for keeping tabs as ever.
colinzeal
20/3/2019
17:44
Incredible 6 percent spread at the close with very low turnover just indicates that the broad understanding of today's deal by your average punter is not there.
aspex
20/3/2019
17:31
Updated list following today's deal.Recent, current and potential future revenue streams confirmed:- GoFigure: shakes, bars and muesli pots - CholBiome (x3 and Daily Maintenance)- Sacco/CSL - HLH BioPharma Vertriebs GmbH - Nutrilinia (LD-LDL and Slimbiome Medical)- Pharmabiota- Galenicum Special Ingredients - Knighton Foods- Cereal Ingredients Inc.- Fine Foods & Pharmaceuticals- Trigen Pharma- Cambridge Commodities - Akums Drugs and Pharma- Seed Health- John Morley's - Alfasigma- Unnamed global corporate ($100B+ turnover) for SweetBiotix manufacturing & distribution.- Unnamed US pharma partner (cholesterol strain)- Bened Biomedical- Bulgarian CholBiome distributor (Velinoff Pharma/Medochem)- CTC Group- Formulation Creations- US Pharma Lab Inc.- Unnamed Greece and Cyprus CholBiome distributor- Unnamed Greece and Cyprus SlimBiome Medical distributor - Zeon Lifesciences - SilvExpo - CholBiome- Biolat - RMS CardioPro- EIWA Trading Co. Ltd- DKSHRevenue not confirmed yet:- Tata X 2 (Slimbiome and LPGOS)- Mystery US Slimbiome customer- Paradise Fruits (Slimbiome)- Beijing Duoite Biotechnology Co., Ltd (LP-LDL distributors via CSL)Products on the market already but not RNSed:- MuscleForm (Aviform Ltd) - Ultra MR Ultimate Meal Replacement - Olliscience - Ollibiotic - Aragan - Biotic•P3- 39ytu - Capsa Food
parob
20/3/2019
15:58
I think the clue is in the rns which reads " market exclusivity is linked to sales orders".
1bokke
20/3/2019
15:08
Anyone know if it’s just Gofigure or if it also involves Slimbiome Medical for this deal?
imnotlong
20/3/2019
14:17
https://lemminginvestors.blogspot.com/ I asked Stephen O'Hara, CEO of the OptiBiotix, if today's announcement is purely B2c via a B2B partnership, and not related to establishing new products and if so, is it safe to assume revenues, sales should be pretty quick, perhaps as quick as H2 this year? Essentially, this agreement takes GoFigure products to a new much bigger level via a partner that has already established partnerships within the consumer market, meaning the typical 9-12 months each B2B deal takes to establish a product from scratch is not the case because this agreement is for existing SlimBiome products. Stephen O'Hara: "Yes. I have built into the agreement a requirement for orders within the financial year. They are a big company with a big network so should be good."
scotty1
20/3/2019
13:33
Rayrac so in your opinion best for companies not to do any deal big companies,good logic there NOT
scotty1
20/3/2019
13:31
Yes seen that over on LSE rafboy Todays London MetroToday 09:58Big Full Page Article on Go Figure - Don't Yo-Yo, give science a go.
scotty1
20/3/2019
13:27
Another advertorial in METRO today I am told. Not seen myself.
rafboy
20/3/2019
13:23
Another advertorial in METRO today I am told.
rafboy
20/3/2019
13:22
He’s right. Can’t see any logic in the deal for opti...they’ve got Opti by the short and curlies. If Opti got more than 1% out of it, I’d be amazed.
rayrac
20/3/2019
12:49
mike with all due respect you bought in and didn't even know who SoH was/is so not much research there mate 😒 mikethebike4 11 Mar '19 - 17:29 - 47322 of 47591 0 1 0 who is SoH ?
scotty1
20/3/2019
12:22
Nobbygnome 'This deals highlights the elegant business model. A big deal with just one of the product areas in big countries with a company which is big in those countries. The exponential growth of revenues is bound to follow with this approach.' See Futura Medical (FUM)for a company with the above philosophy and look where it has got them after 17 years You are entirely in the hands of the 'big company' - even if they want to suppress your product for any reason ! - they obviously don't mention this when doing the original deal
mikethebike4
20/3/2019
11:40
Parob, agreed. The problem we have, is like risky pointed out with my hypothesis, we dont know at what rate revenues per deal are building, until we have an RNS with actual revenue figures we are stuck. I believe it's growing, but the market doesn't like the Adam Reynolds keyboard!
toyin
20/3/2019
11:33
The disconnect between deals/progress and share price won't last forever.All it is going to take is a large deal to break us out of this flag/trading range and we will be away.
parob
20/3/2019
11:29
risky, my £3.75m is looking better by the day!😉
toyin
Chat Pages: 2018  2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  Older
Your Recent History
LSE
OPTI
Optibiotix..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190321 10:25:07